NASDAQ : ESPR
Esperion Therapeutics, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 3.18 USD (At close: Jul 10, 2026) · Market cap 819.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Esperion Therapeutics, Inc. (ESPR) reported revenue of 418.24M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 418.24M | 403.13M | 332.31M | 116.33M | 75.47M | 78.45M |
| Cost of Revenue | 176.54M | 177.08M | 114.84M | 129.37M | 145.89M | 120.19M |
| Gross Profit | 241.70M | 226.06M | 217.47M | -13.04M | -70.42M | -41.74M |
| Selling, General & Admin | 165.91M | 165.79M | 163.07M | 142.52M | 109.08M | 171.74M |
| Operating Expenses | 165.91M | 165.79M | 163.07M | 142.52M | 109.08M | 171.74M |
| Operating Income | 75.79M | 60.27M | 54.40M | -155.56M | -179.50M | -213.48M |
| Interest Expense | -84.97M | -84.60M | -59.25M | -58.98M | -56.81M | -46.35M |
| Interest & Investment Income | 3.60M | 3.50M | 7.60M | 4.40M | 2.40M | 100.00K |
| Other Non Operating Income (Expenses) | 1.00K | -10.00K | 422.00K | 479.00K | 531.00K | 1.24M |
| EBT Excluding Unusual Items | -5.58M | -20.84M | 3.17M | -209.66M | -233.38M | -258.49M |
| Gain (Loss) on Sale of Investments | 412.00K | -279.00K | -12.00K | |||
| Legal Settlements | -18.25M | |||||
| Other Unusual Items | -54.92M | 2.65M | ||||
| Pretax Income | -5.58M | -20.84M | -51.74M | -209.25M | -233.66M | -269.11M |
| Income Tax Expense | 1.84M | 1.84M | ||||
| Net Income | -7.42M | -22.68M | -51.74M | -209.25M | -233.66M | -269.11M |
| Net Income to Common | -7.42M | -22.68M | -51.74M | -209.25M | -233.66M | -269.11M |
| Shares Outstanding (Basic) | 221.67M | 207.87M | 187.18M | 103.11M | 66.41M | 28.90M |
| Shares Outstanding (Diluted) | 221.67M | 207.87M | 187.18M | 103.11M | 66.41M | 28.90M |
| EPS (Basic) | -0.03 | -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
| EPS (Diluted) | -0.03 | -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
| Free Cash Flow | -18.38M | -13.09M | -23.97M | -135.49M | -174.83M | -263.81M |
| Free Cash Flow Per Share | -0.08 | -0.06 | -0.13 | -1.31 | -2.63 | -9.13 |
| Gross Margin | 57.79% | 56.07% | 65.44% | -11.21% | -93.30% | -53.21% |
| Operating Margin | 18.12% | 14.95% | 16.37% | -133.72% | -237.83% | -272.13% |
| Profit Margin | -1.77% | -5.63% | -15.57% | -179.87% | -309.58% | -343.04% |
| Free Cash Flow Margin | -4.39% | -3.25% | -7.21% | -116.46% | -231.64% | -336.29% |
| EBITDA | 75.89M | 60.38M | 54.47M | -155.40M | -179.00M | -212.87M |
| EBITDA Margin | 18.15% | 14.98% | 16.39% | -133.58% | -237.17% | -271.35% |
| D&A For EBITDA | 106.00K | 105.00K | 63.00K | 164.00K | 500.00K | 612.00K |
| EBIT | 75.79M | 60.27M | 54.40M | -155.56M | -179.50M | -213.48M |
| EBIT Margin | 18.12% | 14.95% | 16.37% | -133.72% | -237.83% | -272.13% |
| Revenue as Reported | 418.24M | 403.13M | 332.31M | 116.33M | 75.47M | 78.45M |
| Advertising Expenses | 25.00M | 25.50M | 15.60M | 11.30M | 13.70M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 156.16M | 167.85M | 144.76M | 82.25M | 124.78M | 208.89M |
| Short-Term Investments | 42.09M | 50.44M | ||||
| Cash & Short-Term Investments | 156.16M | 167.85M | 144.76M | 82.25M | 166.86M | 259.33M |
| Receivables | 132.35M | 140.19M | 80.14M | 48.49M | 33.73M | 22.93M |
| Inventory | 159.14M | 145.99M | 108.35M | 65.62M | 35.20M | 34.39M |
| Prepaid Expenses | 11.81M | 8.54M | 4.74M | 4.70M | 10.89M | 12.31M |
| Total Current Assets | 459.46M | 462.57M | 338.00M | 201.06M | 246.68M | 328.97M |
| Property, Plant & Equipment | 3.01M | 3.26M | 5.77M | 4.67M | 1.20M | 2.56M |
| Other Intangible Assets | 56.00K | 56.00K | 56.00K | 56.00K | 56.00K | 56.00K |
| Other Long-Term Assets | 50.00M | |||||
| Total Assets | 462.53M | 465.89M | 343.82M | 205.80M | 247.94M | 381.59M |
| Accounts Payable | 68.41M | 65.07M | 51.65M | 31.72M | 23.04M | 17.56M |
| Accrued Expenses | 20.17M | 23.36M | 24.63M | 28.44M | 18.63M | 21.23M |
| Current Portion of Long-Term Debt | 80.75M | 87.60M | 102.16M | 34.83M | 24.76M | 11.29M |
| Current Portion of Leases | 1.70M | 2.10M | 2.74M | 1.55M | 384.00K | 1.39M |
| Current Unearned Revenue | 43.53M | 34.48M | 8.52M | 25.40M | 3.51M | 5.68M |
| Other Current Liabilities | 85.81M | 88.20M | 56.53M | 34.28M | 21.99M | 16.19M |
| Total Current Liabilities | 300.36M | 300.81M | 246.23M | 156.22M | 92.31M | 73.35M |
| Long-Term Debt | 460.50M | 457.65M | 483.74M | 501.55M | 478.74M | 504.02M |
| Long-Term Leases | 861.00K | 653.00K | 2.57M | 3.02M | 665.00K | 524.00K |
| Long-Term Unearned Revenue | 634.00K | |||||
| Other Long-Term Liabilities | 8.74M | 8.74M | ||||
| Total Liabilities | 770.46M | 767.85M | 732.54M | 660.79M | 571.72M | 578.53M |
| Common Stock | 257.00K | 245.00K | 196.00K | 118.00K | 75.00K | 61.00K |
| Additional Paid-In Capital | 1.40B | 1.38B | 1.27B | 1.15B | 1.07B | 964.40M |
| Retained Earnings | -1.65B | -1.62B | -1.60B | -1.55B | -1.34B | -1.11B |
| Treasury Stock | -55.00M | -55.00M | -55.00M | -55.00M | -55.00M | -55.00M |
| Comprehensive Income & Other | -2.00K | -31.00K | ||||
| Shareholders' Equity | -307.93M | -301.96M | -388.72M | -454.99M | -323.78M | -196.94M |
| Total Liabilities & Equity | 462.53M | 465.89M | 343.82M | 205.80M | 247.94M | 381.59M |
| Total Debt | 543.81M | 548.00M | 591.21M | 540.95M | 504.55M | 517.24M |
| Net Cash (Debt) | -387.65M | -380.15M | -446.45M | -458.70M | -337.69M | -257.90M |
| Net Cash Per Share | -1.75 | -1.83 | -2.39 | -4.45 | -5.09 | -8.92 |
| Filing Date Shares Outstanding | 257.43M | 256.81M | 197.85M | 185.05M | 76.57M | 62.82M |
| Total Common Shares Outstanding | 257.40M | 245.22M | 195.85M | 118.21M | 74.57M | 60.88M |
| Working Capital | 159.10M | 161.76M | 91.77M | 44.84M | 154.38M | 255.62M |
| Book Value Per Share | -1.20 | -1.23 | -1.98 | -3.85 | -4.34 | -3.23 |
| Tangible Book Value | -307.99M | -302.02M | -388.78M | -455.05M | -323.83M | -197.00M |
| Tangible Book Value Per Share | -1.20 | -1.23 | -1.99 | -3.85 | -4.34 | -3.24 |
| Machinery | 855.00K | 855.00K | 855.00K | 1.45M | 1.45M | |
| Construction In Progress | 189.00K | |||||
| Leasehold Improvements | 189.00K | 189.00K | 189.00K | 299.00K | 299.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -7.42M | -22.68M | -51.74M | -209.25M | -233.66M | -269.11M |
| Depreciation & Amortization | 106.00K | 105.00K | 63.00K | 164.00K | 500.00K | 612.00K |
| Other Amortization | 2.90M | 3.01M | 1.50M | 1.70M | 1.62M | 1.62M |
| Loss (Gain) From Sale of Investments | -412.00K | 279.00K | 12.00K | |||
| Stock-Based Compensation | 9.91M | 9.87M | 11.99M | 11.96M | 15.21M | 24.31M |
| Other Operating Activities | 4.05M | 11.25M | 75.07M | 46.68M | 44.59M | 31.26M |
| Change in Accounts Receivable | -51.06M | -60.05M | -31.65M | -14.77M | -10.79M | -10.55M |
| Change in Inventory | -4.89M | -10.63M | -28.87M | -30.42M | -807.00K | -18.26M |
| Change in Accounts Payable | -3.59M | 20.92M | 12.43M | 8.68M | 5.60M | -34.10M |
| Change in Unearned Revenue | 38.99M | 25.96M | -16.88M | 21.89M | -2.81M | 4.66M |
| Change in Other Net Operating Assets | -7.18M | 9.16M | 4.44M | 28.29M | 5.44M | 5.74M |
| Operating Cash Flow | -18.19M | -13.09M | -23.65M | -135.49M | -174.83M | -263.81M |
| Capital Expenditures | -189.00K | -317.00K | ||||
| Investment in Securities | 42.50M | 8.10M | -50.48M | |||
| Investing Cash Flow | -189.00K | -317.00K | 42.50M | 8.10M | -50.48M | |
| Long-Term Debt Issued | 99.73M | |||||
| Long-Term Debt Repaid | -54.91M | -210.09M | ||||
| Net Debt Issued (Repaid) | -54.91M | -54.91M | -110.36M | |||
| Issuance of Common Stock | 114.57M | 98.35M | 105.99M | 65.94M | 90.85M | 222.45M |
| Repurchase of Common Stock | -343.75M | -50.00M | ||||
| Other Financing Activities | 244.00K | -7.26M | 434.60M | -15.48M | -8.24M | 45.77M |
| Financing Cash Flow | 59.90M | 36.18M | 86.48M | 50.46M | 32.61M | 268.22M |
| Net Cash Flow | 41.52M | 23.09M | 62.51M | -42.53M | -134.12M | -46.07M |
| Free Cash Flow | -18.38M | -13.09M | -23.97M | -135.49M | -174.83M | -263.81M |
| Free Cash Flow Margin | -4.39% | -3.25% | -7.21% | -116.46% | -231.64% | -336.29% |
| Free Cash Flow Per Share | -0.08 | -0.06 | -0.13 | -1.31 | -2.63 | -9.13 |
| Levered Free Cash Flow | -49.71M | -52.59M | -65.72M | -129.64M | -135.56M | -192.19M |
| Unlevered Free Cash Flow | 503.50K | -2.72M | -30.18M | -94.48M | -101.67M | -164.84M |
| Cash Interest Paid | 5.83M | 15.51M | 8.02M | |||
| Change in Working Capital | -27.73M | -14.64M | -60.53M | 13.68M | -3.37M | -52.51M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 819.46M | 871.09M | 433.48M | 340.02M | 459.05M | 306.10M |
| Enterprise Value | 1.21B | 1.38B | 848.35M | 756.72M | 814.62M | 726.22M |
| Last Close Price | 3.18 | 3.70 | 2.20 | 2.99 | 6.23 | 5.00 |
| Forward PE | 12.26 | 16.60 | ||||
| PS Ratio | 1.96 | 2.16 | 1.30 | 2.92 | 6.08 | 3.90 |
| PB Ratio | -2.88 | -1.11 | -0.75 | -1.42 | -1.55 | |
| EV/Sales Ratio | 2.89 | 3.42 | 2.55 | 6.50 | 10.79 | 9.26 |
| EV/EBITDA Ratio | 15.91 | 22.85 | 15.58 | |||
| EV/EBIT Ratio | 15.93 | 22.89 | 15.59 | |||
| Debt / Equity Ratio | -1.77 | -1.81 | -1.52 | -1.19 | -1.56 | -2.63 |
| Debt / EBITDA Ratio | 6.94 | 8.70 | 10.29 | |||
| Net Debt / Equity Ratio | -1.26 | -1.26 | -1.15 | -1.01 | -1.04 | -1.31 |
| Net Debt / EBITDA Ratio | 5.11 | 6.30 | 8.20 | -2.95 | -1.89 | -1.21 |
| Net Debt / FCF Ratio | -21.09 | -29.03 | -18.62 | -3.39 | -1.93 | -0.98 |
| Asset Turnover | 1.06 | 1.00 | 1.21 | 0.51 | 0.24 | 0.21 |
| Inventory Turnover | 1.37 | 1.39 | 1.32 | 2.57 | 4.19 | 4.76 |
| Quick Ratio | 0.96 | 1.02 | 0.91 | 0.84 | 2.17 | 3.85 |
| Current Ratio | 1.53 | 1.54 | 1.37 | 1.29 | 2.67 | 4.49 |
| Return on Assets (ROA) | 12.04% | 9.30% | 12.37% | -42.86% | -35.64% | -36.31% |
| Return on Capital Employed (ROCE) | 46.70% | 36.50% | 55.70% | -313.80% | -115.30% | -69.30% |
| Earnings Yield | -0.91% | -2.60% | -11.94% | -61.54% | -50.90% | -87.91% |
| FCF Yield | -2.24% | -1.50% | -5.53% | -39.85% | -38.09% | -86.18% |
| Buyback Yield / Dilution | -14.32% | -11.05% | -81.54% | -55.26% | -129.76% | -5.20% |